CAS 592542-59-1 appears in our catalog under these names: Rigosertib, 95%, Rigosertib, Rigosertib/ 97.33% (existing batch purity), Rigosertib-d6, Rigosertib 98%. Offered by: Combi-blocks, TRC, TargetMol, GLPBio, Biosynth. Available pack sizes: 250mg, 100mg, 1g, 500mg, 2mg, 5mg, 10mg, 10mM (in 1ml dmso).
Rigosertib is an N-[2-methoxy-5-({[2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl}methyl)phenyl]glycine in which the double bond has E-configuration. It is a non-ATP-competitive inhibitor of PLK1 with an IC50 of 9 nM and exhibits anti-cancer properties. It has a role as an EC 2.7.11.21 (polo kinase) inhibitor, an antineoplastic agent, a microtubule-destabilising agent and an apoptosis inducer. It is a conjugate acid of a rigosertib(1-).
Source: ChEBI
| Molecular formula | C21H25NO8S |
|---|---|
| Molecular weight | 451.5 g/mol |
| IUPAC name | 2-[2-methoxy-5-[[(E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonylmethyl]anilino]acetic acid |
| InChIKey | OWBFCJROIKNMGD-BQYQJAHWSA-N |
| SMILES | COC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)NCC(=O)O |
Computed by PubChem (NCBI)